Digestive & Intestinal Remedies (Pharmacies) - Argentina

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$136.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.50%, resulting in a market volume of US$154.20m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.96 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Argentina is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trend. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Argentina are favoring natural and herbal remedies. Consumers are increasingly seeking products that are perceived as more natural and less chemically based. This preference for natural remedies is driven by a growing awareness of the potential side effects of traditional pharmaceutical products and a desire for more holistic approaches to healthcare. Trends in the market are also playing a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Argentina. There is a rising demand for digestive and intestinal remedies due to changing dietary habits and lifestyles. The consumption of processed and fast foods has increased, leading to a higher incidence of digestive issues such as indigestion, acid reflux, and constipation. As a result, consumers are seeking over-the-counter remedies to alleviate these symptoms. Local special circumstances in Argentina are contributing to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. The country has a high prevalence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). These conditions affect a significant portion of the population and create a need for accessible and effective remedies. Additionally, the relatively low cost of digestive and intestinal remedies compared to prescription medications makes them a more affordable option for many consumers. Underlying macroeconomic factors are also driving the development of the Digestive & Intestinal Remedies (Pharmacies) market in Argentina. The country has experienced economic challenges in recent years, leading to a decline in disposable income for many consumers. As a result, individuals may be more inclined to self-medicate and seek affordable remedies for common digestive issues rather than visit a healthcare professional. This has contributed to the increased demand for over-the-counter remedies in pharmacies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Argentina is experiencing growth and development due to customer preferences for natural remedies, changing dietary habits, the high prevalence of gastrointestinal disorders, and underlying macroeconomic factors. As these factors continue to shape the market, it is likely that the demand for digestive and intestinal remedies will continue to rise.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.